GIM
INVA icon

Glenmede Investment Management’s Innoviva INVA Stock Holding History

Glenmede Investment Management’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$376K Buy
20,608
+38
+0.2% +$741 ﹤0.01% 1036
2025
Q2 		$413K Buy
+20,570
New +$396K ﹤0.01% 997

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Glenmede Investment Management's INVA Position: Q3 2025 in Review

Glenmede Investment Management increased its Innoviva (INVA) stake by 0.18% in Q3 2025, buying an estimated $741 and bringing the position to 20,608 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Glenmede Investment Management first reported a position in INVA in Q2 2025 and has held it in 2 quarters since. The position peaked at $413K in Q2 2025. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

  • Glenmede Investment Management held 20,608 shares of Innoviva worth $376K as of Q3 2025.
  • Glenmede Investment Management bought 38 Innoviva shares in Q3 2025, an estimated $741.
  • Innoviva made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1036 holding.
  • Glenmede Investment Management first reported a position in Innoviva in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Innoviva position peaked at $413K in Q2 2025.
  • 264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.